Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies

Virology

Volumn 259, Issue 2, 1999, Pages 314-323

  Altmeyer, Ralf ^a   Mordelet, Elodie ^a   Girard, Marc ^a   Vidal, Catherine ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOPROTEIN GP 120;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN BHK; COGNITIVE DEFECT; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; VIRUS DETECTION; VIRUS ENVELOPE; VIRUS SHEDDING;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RABBIT FIBROMA VIRUS; RNA VIRUSES; SEMLIKI FOREST VIRUS;

EID: 0033526846     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9780     Document Type: Article

References (33)

1. Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M., Dawson V. L. Immunologic NO synthase - Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
2. Bagetta G., Corasaniti M. T., Aloe L., Berliocchi L., Costa N., Finazziagro A., Nistico G. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl. Acad. Sci. USA. 93:1996;928-933.
3. Barks J. D. E., Sun P., Malinak C., Silverstein F. S. gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Exp. Neurol. 132:1995;123-133.
4. Benos D. J., Hahn B. H., Bubien J. K., Ghosh S. K., Mashburn N. A., Chaikin M. A., Shaw G. M., Benveniste E. N. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc. Natl. Acad. Sci. USA. 91:1994;494-498.
5. Berglund P., Sjoberg M., Garoff H., Atkins G. J., Sheahan B. J., Liljestrom P. Semliki Forest virus expression system: Production of conditionally infectious recombinant particles. Bio/Technology. 11:1993;916-920.
6. Berrada F., Ma D. M., Michaud J., Doucet G., Giroux L., Kessouselbaz A. Neuronal expression of human immunodeficiency virus type 1 Env proteins in transgenic mice - Distribution in the central nervous system and pathological alterations. J. Virol. 69:1995;6770-6778.
7. Bubien J. K., Benveniste E. N., Benos D. J. HIV-gp120 activates large-conductance apamin-sensitive potassium channels in rat astrocytes. Am. J. Physiol. Cell Physiol. 37:1995;C1440-C1449.
8. Byrnes A. P., MacLaren R. E., Charlton H. M. Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16:1996;3045-3055.
9. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
10. Cocchi F., Devico A. L., Garzinodemo A., Cara A., Gallo R. C., Lusso P. The V3 domain of the HIV-1 gp120 Envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1996;1244-1247.
11. Dawson V. L., Dawson T. M., Uhl G. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
12. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., Dotti C. G. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14:1995;4932-4938.
13. Dubois-Dalcq M., Altmeyer R., Chiron M., Wilt S. HIV interactions with cells of the nervous system. Curr. Opin. Neurobiol. 5:1995;647-655.
14. Earl P. L., Moss B. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. AIDS Res. Hum. Retroviruses. 9:1993;589-594.
15. Gorny M. K., Conley A. J., Karwowska S., Buchbinder A., Xu J. Y., Emini E. A., Koenig S., Zolla-Pazner S. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:1992;7538-7542.
16. Grant I., Heaton R. K., Atkinson J. H. Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr. Top. Microbiol. Immunol. 202:1995;11-32.
17. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adlebiassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J., Lantos P. Neuropathology of early HIV-1 infection. Brain Pathol. 6:1996;1-12.
18. Liljeström P., Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology. 9:1991;1356-1361.
19. Lipton S. A., Gendelman H. E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:1995;934-940.
20. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1995;1075-1082.
21. Sacktor N., McArthur J. Prospects for therapy of HIV-associated neurologic diseases. J. Neurovirol. 3:1997;89-101.
22. Shrikant P., Benos D. J., Tang L. P., Benveniste E. N. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells - Involvement of Janus kinase signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol. 156:1996;1307-1314.
23. Shugars D. C., Wild C. T., Greenwell T. K., Matthews T. J. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70:1996;2982-2991.
24. Sullivan N., Sun Y., Li J., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:1995;4413-4422.
25. Thomas F. P., Chalk C., Lalonde R., Robitaille Y., Jolicoeur P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68:1994;7099-7107.
26. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice [see comments]. Nature. 367:1994;188-193.
27. Trillopazos G., Everall I. P. Neuronal damage and its relation to dementia in acquired immunodeficiency syndrome (AIDS). Pathobiology. 64:1996;295-307.
28. Trkola A., Pomales A. B., Yuan H., Korber B., Maddon P. J., Allaway G. P., Katinger H., Barbas C. F., Burton D. R., Ho D. D., Moore J. P. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:1995;6609-6617.
29. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J. P., Katinger H. Human monoclonal antibody 2g12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1996;1100-1108.
30. VanCott T. C., Veit S. C., Kalyanaraman V., Earl P., Birx D. L. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. J. Immunol. Methods. 183:1995;103-117.
31. Verrier F. C., Charneau P., Altmeyer R., Laurent S., Borman A. M., Girard M. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native Envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate. Proc. Natl. Acad. Sci. USA. 94:1997;9326-9331.
32. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41 [see comments]. Nature. 387:1997;426-430.
33. Zolla-Pazner S., O'Leary J., Burda S., Gorny M. K., Kim M., Mascola J., McCutchan F. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:1995;3807-3815.